Is there a role for immune responses in the pathogenesis of hepatitis C?

Journal of Hepatology

Volumn 25, Issue 2, 1996, Pages 232-238

  Mondelli, Mario U ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY RESPONSE; B LYMPHOCYTE; HEPATITIS C; HUMAN; IMMUNE RESPONSE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

EID: 0030220371     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(96)80080-8     Document Type: Review

References (52)

1. Alter H.J. To C or not to C: these are the questions. Blood. 85:1995;1681-1695.
2. Simmonds P. Variability of hepatitis C virus. Hepatology. 21:1995;570-583.
3. Sloan-Lancaster J., Evavold B.D., Allen P.M. Induction of T-cell anergy by altered T-cell receptor ligand on live antigen-presenting cells. Nature. 363:1993;156-159.
4. Bertoletti A., Sette A., Scaccaglia P., Levrero M., Chisari F.V., Fiaccadori F., Ferrari C. Natural variants of cytotoxic epitopes are T cell receptor antagonists for antiviral cytotoxic T cells. Nature. 369:1994;407-410.
5. Kohler H., Müller S., Nara P.L. Deceptive imprinting in the immune response against HIV-1. Immunol Today. 15:1994;475-478.
6. Farci P., Alter H.J., Wong D.C., Miller R.H., Govindarajan S., Engle R., Shapiro M., Purcell R.H. Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc Natl Acad Sci USA. 91:1994;7792-7796.
7. Shimizu Y.K., Hijikata M., Iwamoto A., Alter H.J., Purcell R.H., Yoshikura H. Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. J Virol. 68:1994;1494-1500.
8. Weiner A.J., Geysen H.M., Christopherson C., Hall J.E., Mason T.J., Saracco G., Bonino F., Crawford K., Marion C.D., Crawford K.A., Brunetto M., Barr P.J., Miyamura T., McHutchinson J., Houghton M. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infection. Proc Natl Acad Sci USA. 89:1992;3468-3472.
9. Kato N., Sekiya H., Ootsuyama Y., Nakazawa T., Hijikata M., Ohkohshi S., Shimotohno K. Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus. J Virol. 67:1993;3923-3930.
10. Van Doorn L.-J., Capriles I., Maertens G., DeLeys R., Murray K., Kos T., Schellekens H., Quint W. Sequences evolution of the hypervariable region in the putative envelope region E2/NS1 of hepatitis C virus is correlated with specific humoral immune responses. J Virol. 69:1995;773-778.
11. Chien D.Y., Choo Q.-L., Ralston R., Spaete R., Tong M., Houghton M., Kuo G. Persistence of HCV despite antibodies to both putative envelope glycoproteins (Letter). Lancet. 342:1993;933.
12. Taniguchi S., Okamoto H., Sakamoto M., Kojima M., Tsuda F., Tanaka T., Munekata E., Muchmore E.E., Peterson D.A., Mishiro S. A structurally flexible and antigenically variable N-terminal domain of the hepatitis C virus E2/NS1 protein: implication for an escape from antibody. Virology. 195:1993;297-301.
13. Farci P., Shimoda A., Wong D., Cabezon T., De Gioannis D., Strazzera A., Shapiro M., Alter H.J., Purcell R.H. Prevention of HCV infection in chimpanzees by hyperimmune serum against the hypervariable region 1 (HVR1): emergence of neutralization escape mutants in vivo (Abstract). Hepatology. 22:1995;220A.
14. Scarselli E., Cerino A., Esposito G., Silini E., Mondelli M.U., Traboni C. Occurrence of antibodies reactive with more than one variant of the putative envelope glycoprotein (E2; gp70) hypervariable region 1 in hepatitis C viremic patients. J Virol. 69:1995;4407-4412.
15. Rosa D., Campagnoli S., Moretto C., Guenzi E., Cousens L., Chin M., Dong C., Weiner A.J., Lau J.Y.N., Choo Q.-L., Chien D., Pileri P., Houghton M., Abrignani S. A quantitative test to estimate neutralizing antibodies to hepatitis C virus: cytofluorometric assessment of envelope glycoprotein E2 binding to target cells. Proc Natl Acad Sci USA. 1996;. in press.
16. Nasoff M.S., Zebedee S.L., Inchauspé G., Prince A. Identification of an immunodominant epitope within the capsid protein of hepatitis C virus. Proc Natl Acad Sci USA. 88:1991;5462-5466.
17. Hosein B., Fant C.T., Popowsky M.A., Ye J., Zhang M., Wang C.Y. Improved serodiagnosis of hepatitis C virus infection with synthetic peptide antigen from capsid protein. Proc Natl Acad Sci USA. 88:1991;3647-3651.
18. Okamoto H., Tsuda F., Machida A., Munekata E., Akahane Y., Sugai Y., Mashiko K., Mitsui T., Tanaka T., Miyakawa Y., Mayumi M. Antibodies against synthetic oligopeptides deduced from the putative core gene for the diagnosis of hepatitis C virus infection. Hepatology. 15:1992;180-186.
19. Cerino A., Mondelli M.U. Identification of an immunodominant B-cell epitope on the hepatitis C virus non-structural region defined by human monoclonal antibodies. J Immunol. 147:1991;2692-2696.
20. Ferroni P., Mascolo G., Zaninetti M., Colzani D., Pregliasco F., Pirisi M., Barbone F., Gasparini V. Identification of four epitopes in hepatitis C virus core protein. J Clin Microbiol. 31:1993;1586-1591.
21. Cerino A., Boender P., Rosa C., La Monica N., Habets W., Mondelli M.U. A human monoclonal antibody specific for the N-terminus of hepatitis C virus nucleocapsid protein. J Immunol. 151:1993;7005-7015.
22. Mondelli M.U., Cerino A., Boender P., Oudshoorn P., Middeldorp J., Fipaldini C., La Monica N., Habets W. Significance of the immune response to a major, conformational B cell epitope on the hepatitis C virus NS3 region defined by a human monoclonal antibody. J Virol. 68:1994;4829-4836.
23. Failla C., Tomei L., De Francesco R. Both NS3 and NS4a are required for proteolytic processing of hepatitis C virus non-structural proteins. J Virol. 68:1994;3753-3760.
24. Bartenschlager R., Ahlborn-Laake L., Mous J., Jacobsen H. Kinetic and structural analyses of hepatitis C virus polyprotein processing. J Virol. 68:1994;5045-5055.
25. Botarelli P., Brunetto M.R., Minutello M.A., Calvo P., Unutmaz D., Weiner A.J., Choo Q.-L., Shuster J.R., Kuo G., Bonino F., Houghton M., Abrignani S. T-lymphocyte response to hepatitis C virus in different clinical courses of infection. Gastroenterology. 104:1993;58-67.
26. Schupper H., Hayashi P., Scheffel J., Aceituno S., Paglieroni T., Holland P.V., Zeldis J.B. Peripheral blood mononuclear cell response to recombinant hepatitis C virus antigens in patients with chronic hepatitis C. Hepatology. 18:1993;1055-1060.
27. Tsai S.-L., Chen P.-J., Hwang L.-M., Kao J.-H., Huang J.-H., Chang T.-H., Chen D.-S. Immune response to a hepatitis C virus nonstructural protein in chronic hepatitis C virus infection. J Hepatol. 21:1994;403-411.
28. Ferrari C., Valli A., Galati L., Penna A., Scaccaglia P., Giuberti T., Schianchi C., Missale G., Marin M.G., Fiaccadori F. T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections. Hepatology. 19:1994;286-295.
29. Koskinas J., McFarlane B.M., Nouri-Aria K.T., Tibbs C.J., Mizokami M., Donaldson P.T., McFarlane I.G., Williams R. Cellular and humoral immune reactions against autoantigens and hepatitis C viral antigens in chronic hepatitis C. Gastroenterology. 107:1994;1436-1442.
30. Hoffmann R.M., Diepolder H.M., Zachoval R., Zwiebel F., Jung M.C., Scholz S., Nitschko H., Riethmüller G., Pape G.R. Mapping of immunodominant CD4+ T lymphocyte epitopes of hepatitis C virus antigens and their relevance during the course of chronic infection. Hepatology. 21:1995;632-638.
31. Diepolder H.M., Zachoval R., Hoffmann R.M., Weirenga E.A., Santantonio T., Jung M.-C., Eichenlaub D., Pape G.R. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet. 346:1995;1006-1007.
32. Leroux-Roels G., Alvarado Esquivel C., DeLeys R., Stuyver L., Elewaut A., Philippé J., Desombere I., Paradijs J., Maertens G. Lymphoproliferative responses to hepatitis C virus core, E1, E2, and NS3 in patients with chronic hepatitis C infection treated with interferon alfa. Hepatology. 23:1996;8-16.
33. Minutello M.A., Pileri P., Unutmaz D., Censini S., Kuo G., Houghton M., Brunetto M.R., Bonino F., Abrignani S. Compartmentalization of T lymphocytes to the site of disease: intrahepatic CD4+ cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C. J Exp Med. 178:1993;17-25.
34. Ferrari C., Penna A., Bertoletti A., Valli A., Degli Antoni A., Giuberti T., Cavalli A., Petit M.-A., Fiaccadori F. Cellular immune response to hepatitis B virus (HBV)-encoded antigens in acute and chronic HBV infections. J Immunol. 145:1990;3442-3449.
35. Mondelli M., Alberti A., Tremolada F., Williams R., Eddleston A.L.W.F., Realdi G. In vitro cell-mediated cytotoxicity for autologous liver cells in chronic non-A, non-B hepatitis. Clin Exp Immunol. 63:1986;147-155.
36. Poralla T., Hütteroth T.H., Meyer zum Büschenfelde K.-H. Cellular cytotoxicity against autologous hepatocytes in acute and chronic non-A, non-B hepatitis. Gut. 25:1984;114-120.
37. Liaw Y.-F., Lee C.-S., Tsai S.-L., Liaw B.-W., Chen T.-C., Sheen I.-S., Chu C.-M. T-cell-mediated autologous hepatocytotoxicity in patients with chronic hepatitis C virus infection. Hepatology. 22:1995;1368-1373.
38. Falk K., Roetzscke O., Stevanovic S., Jung G., Rammensee H.-G. Allele-specific motifs revealed by sequencing of self peptides eluted from MHC molecules. Nature. 351:1991;290-296.
39. Battegay M., Fikes J., Di Bisceglie A.M., Wentworth P.A., Sette A., Celis E., Ching W.-M., Grakoui A., Rice C.M., Kurokohchi K., Berzofsky J.A., Hoofnagle J.H., Feinstone S.M., Akatsuka T. Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. J Virol. 69:1995;2462-2470.
40. Shirai M., Okada H., Nishioka M., Akatsuka T., Wychowski C., Houghten R., Pendleton C.D., Feinstone S.M., Berzofsky J.A. An epitope in hepatitis C virus core region recognized by cytotoxic T cells in mice and humans. J Virol. 68:1994;3334-3342.
41. Cerny A., McHutchinson J.G., Pasquinelli C., Brown M.E., Brothers M.A., Grabscheid B., Fowler P. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA-A2.1 binding motif. J Clin Invest. 95:1995;521-530.
42. Cerny A., Fowler C., Brothers M.A., Houghton M., Schlicht H.J., Chisari F.V. Induction in vitro of a primary human antiviral cytotoxic T cell response. Eur J Immunol. 25:1995;627-630.
43. Shirai M., Arichi T., Nishioka M., Nomura T., Ikeda K., Kawanishi K., Engelhard VH, Feinstone SM, Berzofsky JA. Cytotoxic T lymphocyte (CTL) responses of HLA-A2.1-transgenic mice specific for hepatitis C viral peptides predict epitopes for CTL of human carrying HLA-A2.1. J Immunol. 154:1995;2733-2742.
44. Koziel MJ, Dudley D, Wong JT, Diestag JL, Houghton M, Ralston R, Walker BD. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J Immunol. 149:1992;3339-3344.
45. Koziel MJ, Dudley D, Afdhal N, Choo Q-L, Houghton M, Ralston R, Walker BD. Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV. J Virol. 67:1993;7522-7532.
46. Koziel MJ, Dudley D, Afdhal N, Grakoui A, Rice CM, Choo Q-L, Houghton M, Walker BD. HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release. J Clin Invest. 96:1995;2311-2321.
47. Wong JT, Colvin R. Bispecific monoclonal antibodies: selective binding and complement fixation to cells that express two different surface antigens. J Immunol. 139:1987;1369-1374.
48. Erickson AL, Houghton M, Choo Q-L, Weiner AJ, Ralston R, Muchmore E, Walker CM. Hepatitis C virus-specific CTL responses in the liver of chimpanzees with acute and chronic hepatitis C. J Immunol. 151:1993;4189-4199.
49. Ando K, Moriyama T, Guidotti L, Wirth S, Schreiber R, Hans-Jurgen S, Huang S-N, Chisari FV. Mechanism of class I-restricted immunopathology. A transgenic mouse model of fulminant hepatitis. J Exp Med. 178:1993;1541-1554.
50. Kurilla MG, Swaminathan S, Welsh RM, Kieff E, Brutkiewicz RR. Effects of virally expressed interleukin-10 on vaccinia virus infection in mice. J Virol. 67:1993;7623-7628.
51. Shirai M, Akatsuka T, Pendleton CD, Houghton R, Wynchowski C, Mihalik K, Feinstone SM, Berzofsky JA. Induction of cytotoxic T cells to a cross-reactive epitope in the hepatitis C virus nonstructural RNA polymerase-like protein. J Virol. 66:1992;4098-4106.
52. Kita H, Moriyama T, Kaneko T, Harase I, Nomura M, Miura H, Nakamura I, Yazaki Y, Imawari M. HLA B44-restricted cytotoxic T lymphocytes recognizing an epitope on hepatitis C virus nucleocapsid protein. Hepatology. 18:1993;1039-1044.